![Gary Lyons](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Lyons
Chairman at
TRAVERE THERAPEUTICS, INC.
Net worth: 22 M $ as of 2026-05-30
Profile
Gary A. Lyons is a businessperson who founded GL Biomed and who has been the head of 5 different companies. Mr. Lyons is Chairman of Rigel Pharmaceuticals, Inc., Chairman of Travere Therapeutics, Inc. and President of GL Biomed. Mr. Lyons is also on the board of Neurocrine Biosciences, Inc. (former President, Chief Executive Officer & Director), Eledon Pharmaceuticals, Inc. and Brickell Biotech, Inc. He previously occupied the position of Executive Chairman of NeurogesX, Inc., Vice President-Business Development & Sales at Genentech, Inc. and Sales Director-American Critical Care at American Hospital Supply Corp. Mr. Lyons received an undergraduate degree from the University of New Hampshire and an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-26 | 122,141 ( 0.12% ) | 19 M $ | 2026-05-30 | |
| 2026-05-18 | 61,500 ( 0.07% ) | 3 M $ | 2026-05-30 |
Gary Lyons active positions
| Companies | Position | Start |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Director/Board Member | 1993-01-31 |
| TRAVERE THERAPEUTICS, INC. | Chairman | 2016-05-17 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Director/Board Member | 2017-12-31 |
GL Biomed | Founder | 2008-02-29 |
Former positions of Gary Lyons
| Companies | Position | End |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Director/Board Member | 2024-05-21 |
| FRESH TRACKS THERAPEUTICS, INC. | Director/Board Member | 2023-10-01 |
| ELEDON PHARMACEUTICALS, INC. | Director/Board Member | 2023-06-20 |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Director/Board Member | 2019-07-31 |
| PLUS THERAPEUTICS, INC. | Director/Board Member | 2019-01-29 |
Training of Gary Lyons
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Poniard Pharmaceuticals, Inc.
 Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
American Hospital Supply Corp.
 American Hospital Supply Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells lines of medical care products | Health Technology |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeurogesX, Inc.
 NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pain management therapies | Health Technology |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
GL Biomed | |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Fresh Tracks Therapeutics, Inc.
 Fresh Tracks Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops and manufactures prescription therapeutics products for the treatment of autoimmune, inflammatory and debilitating diseases | Health Technology |
Kalobios Pharmaceuticals, Inc. | Technology Services |
- Stock Market
- Insiders
- Gary Lyons
